RecruitingNot ApplicableNCT05206708

Assesment of the Efficacy of Personalized Parent-child Psychotherapy in Children Under 3 Years Old

Assesment of the Efficacy of Personalized Parent-child Psychotherapy Evaluating Symptoms in Children Under 3 Years Old and Parent-child Interaction.


Sponsor

Centre Hospitalier Universitaire de Besancon

Enrollment

234 participants

Start Date

Feb 28, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to assess the efficacy at 4 months of a personalized strategy comparatively to a standard Psychodynamic Integrative Therapy, on childrens' symptom improvment


Eligibility

Max Age: 3 Years

Inclusion Criteria2

  • Families who are requesting a consultation for functional or behavioural problems of their child
  • Children under the age of 3

Exclusion Criteria4

  • Parents suffering from a severe untreated psychiatric disorder
  • Difficulties in speaking French
  • Children with Autistic spectrum disorder
  • Families already in care

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALPersonalized psychotherapy

Strategy including personalized psychotherapy

BEHAVIORALStandard of care

Strategy based standard intregrative psychodynamic therapy


Locations(4)

CHU de Besançon

Besançon, France

CHU de Montpellier

Montpellier, France

GHU Paris Psychiatrie et Neurosciences

Paris, France

CHU de Reims

Reims, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05206708


Related Trials